For citations:
Shilov SN, Berezikova EN, Popova AA, Samsonova EN, Teplyakov AT, Grakova EV, Kopeva KV, Molokov AV, Yakovleva IV. Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis. Meditsinskiy sovet = Medical Council. 2021;(7):78-86. (In Russ.) https://doi.org/10.21518/2079-701X-2021-7-78-86